Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Long-Term Investments (2022 - 2024)

Abpro Holdings' (ABPO) quarterly Long-Term Investments came in at $1.4 million in Q3 2024, down 96.1% YoY from $36.5 million in Q4 2023, and down 81.32% on a QoQ basis from $7.6 million in Q2 2024.

Abpro Holdings (ABPO) Long-Term Investments (2022 - 2024) Analysis & Trends

Abpro Holdings (ABPO) has 3 years of Long-Term Investments data on file, last reported at $1.4 million in Q3 2024.

  • Quarterly Long-Term Investments fell 96.1% year-over-year to $1.4 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.4 million (down 96.1% YoY) and the FY2023 annual result came in at $29.7 million, changed N/A from the prior year.
  • Long-Term Investments fell to $1.4 million in Q3 2024, from $7.6 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $313.1 million in Q1 2023 to a low of $1.4 million in Q3 2024.
  • A 3-year average of $135.1 million and a median of $36.2 million in 2023 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2023 — Long-Term Investments grew 2.37% — and 2024, when it slumped 97.6%.
  • Tracing ABPO's Long-Term Investments over 3 years: stood at $307.5 million in 2022, then sank by 90.33% to $29.7 million in 2023, then plunged by 95.21% to $1.4 million in 2024.
  • The last three Long-Term Investments figures came in at $1.4 million (Q3 2024), $7.6 million (Q2 2024), and $7.5 million (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.77 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 22.17 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 372.10 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 1.42 Mn
Jun 30, 2024 7.62 Mn
Mar 31, 2024 7.51 Mn
Dec 31, 2023 29.73 Mn
Sep 30, 2023 36.47 Mn
Jun 30, 2023 36.00 Mn
Mar 31, 2023 313.07 Mn
Sep 30, 2022 307.55 Mn
Jun 30, 2022 306.07 Mn
Mar 31, 2022 305.83 Mn